Assignee
XWPHARMA LTD
KY·25 granted patents·13 pending applications·25 citations·filing 2020–2025
Top patents by PatentIndex Score
38 records- 0197US11279669B2Methods of synthesizing 4-valyloxybutyric acidXWPHARMA LTD·Filed 2021·Granted Mar 22, 2022·4 cites·28 claims
- 0295US12030834B2Methods of synthesizing 4-valyloxybutyric acidXWPHARMA LTD·Filed 2023·Granted Jul 9, 2024·1 cites·7 claims
- 0395US11395801B2Modified release compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2021·Granted Jul 26, 2022·9 cites·18 claims
- 0493US11420955B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXWPHARMA LTD·Filed 2021·Granted Aug 23, 2022·2 cites·14 claims
- 0592US12209060B2Ketamine derivatives and compositions thereofXWPHARMA LTD·Filed 2022·Granted Jan 28, 2025·1 cites·24 claims
- 0692US11746081B2Methods of synthesizing 4-valyloxybutyric acidXWPHARMA LTD·Filed 2022·Granted Sep 5, 2023·1 cites·16 claims
- 0792US11510892B2Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2022·Granted Nov 29, 2022·2 cites·15 claims
- 0889US11304906B2Controlled release granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2021·Granted Apr 19, 2022·2 cites·16 claims
- 0988US11896573B2Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2021·Granted Feb 13, 2024·1 cites·11 claims
- 1088US11357734B2Pharmaceutical granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2021·Granted Jun 14, 2022·1 cites·18 claims
- 1187US2025122149A1Ketamine derivatives and compositions thereofXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 1287US2024351975A1Methods of synthesizing 4-valyloxybutyric acidXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 1386US11440874B2Ketamine derivatives and compositions thereofXWPHARMA LTD·Filed 2020·Granted Sep 13, 2022·1 cites·18 claims
- 1485US12396956B2Modified release compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2024·Granted Aug 26, 2025·0 cites·19 claims
- 1585US2026097009A1Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 1682US2025352481A1Modified release compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 1781US12172980B2Compounds as neuronal histamine receptor-3 antagonists and uses thereofXWPHARMA LTD·Filed 2022·Granted Dec 24, 2024·0 cites·15 claims
- 1880US2025352496A1Pharmaceutical compositions and oral dosage forms of ketamine derivativesXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 1980US2024156772A1Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 2079US12396966B2Pharmaceutical compositions and oral dosage forms of ketamine derivativesXWPHARMA LTD·Filed 2023·Granted Aug 26, 2025·0 cites·23 claims
- 2179US11944597B2Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2022·Granted Apr 2, 2024·0 cites·22 claims
- 2279US11639337B2Bicyclic heteroaryl derivatives and preparation and uses thereofXWPHARMA LTD·Filed 2022·Granted May 2, 2023·0 cites·13 claims
- 2378US11925710B2Modified release compositions of a GAMMA-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 2477US11690811B2Pharmaceutical compositions and oral dosage forms of ketamine derivativesXWPHARMA LTD·Filed 2022·Granted Jul 4, 2023·0 cites·8 claims
- 2576US12234226B2Compounds as nuclear transport modulators and uses thereofXWPHARMA LTD·Filed 2023·Granted Feb 25, 2025·0 cites·14 claims
- 2676US2025041258A1Pharmaceutical compositions of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 2776US2025041425A1Excipient granulationsXWPHARMA LTD·Filed 2024·Application pending·0 cites
- 2874US2024130996A1Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivativeXWPHARMA LTD·Filed 2023·Application pending·0 cites
- 2974US2021130281A1Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereofXWPHARMA LTD·Filed 2021·Application pending·0 cites
- 3073US12337066B2Controlled release granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2022·Granted Jun 24, 2025·0 cites·21 claims
- 3172US11401249B2Bicyclic heteroaryl derivatives and preparation and uses thereofXWPHARMA LTD·Filed 2020·Granted Aug 2, 2022·0 cites·12 claims
- 3272US2025262157A1Controlled release granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2025·Application pending·0 cites
- 3370US11905247B2Compounds as neurokinin-1 receptor antagonists and uses thereofXWPHARMA LTD·Filed 2021·Granted Feb 20, 2024·0 cites·19 claims
- 3468US2022323366A1Pharmaceutical granulations of water-soluble active pharmaceutical ingredientsXWPHARMA LTD·Filed 2022·Application pending·0 cites
- 3566US2024092727A1Crystalline 4-((l-valyl)oxy)butanoic acidXWPHARMA LTD·Filed 2023·Application pending·0 cites
- 3663US11312703B2Reactive oxygen species scavengers and use for treating diseasesXWPHARMA LTD·Filed 2020·Granted Apr 26, 2022·0 cites·16 claims
- 3761US11767313B2Compounds as nuclear transport modulators and uses thereofXWPHARMA LTD·Filed 2020·Granted Sep 26, 2023·0 cites·19 claims
- 3859US11692008B2Preparation and uses of reactive oxygen species scavenger derivativesXWPHARMA LTD·Filed 2020·Granted Jul 4, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when XWPHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →